| Literature DB >> 32604796 |
Claudia Dompe1,2, Wiesława Kranc3, Karol Jopek2, Katarzyna Kowalska2, Sylwia Ciesiółka2, Błażej Chermuła4, Artur Bryja3, Maurycy Jankowski3, Joanna Perek3, Małgorzata Jozkowiak5, Lisa Moncrieff1,2, Greg Hutchings1,3, Krzysztof Janowicz1,3, Leszek Pawelczyk4, Małgorzata Bruska3, James Petitte6, Paul Mozdziak7, Magdalena Kulus8, Hanna Piotrowska-Kempisty5, Robert Z Spaczyński4, Michał Nowicki2, Bartosz Kempisty2,3,8,9.
Abstract
Granulosa cells (GCs) have many functions and are fundamental for both folliculogenesis and oogenesis, releasing hormones and communicating directly with the oocyte. Long-term in vitro cultures of GCs show significant stem-like characteristics. In the current study, RNA of human ovarian granulosa cells was collected at 1, 7, 15 and 30 days of long-term in vitro culture. Understanding the process of differentiation of GCs towards different cell lineages, as well as the molecular pathways underlying these mechanisms, is fundamental to revealing other possible stemness markers of this type of cell. Identifying new markers of GC plasticity may help to understand the aetiology and recurrence of a wide variety of diseases and health conditions and reveal possible clinical applications of the ovarian tissue cells, affecting not only the reproductive ability but also sex hormone production. Granulosa cells were the subject of this study, as they are readily available as remnant material leftover after in vitro fertilisation procedures and exhibit significant stem-like characteristics in culture. The change in gene expression was investigated through a range of molecular and bioinformatic analyses. Expression microarrays were used, allowing the identification of groups of genes typical of specific cellular pathways. This candidate gene study focused on ontological groups associated with muscle cell morphogenesis, structure, development and differentiation, namely, "muscle cell development", "muscle cell differentiation", "muscle contraction", "muscle organ development", "muscle organ morphogenesis", "muscle structure development", "muscle system process" and "muscle tissue development". The results showed that the 10 most upregulated genes were keratin 19, oxytocin receptor, connective tissue growth factor, nexilin, myosin light chain kinase, cysteine and glycine-rich protein 3, caveolin 1, actin, activating transcription factor 3 and tropomyosin, while the 10 most downregulated consisted of epiregulin, prostaglandin-endoperoxide synthase 2, transforming growth factor, interleukin, collagen, 5-hydroxytryptmine, interleukin 4, phosphodiesterase, wingless-type MMTV integration site family and SRY-box 9. Moreover, ultrastructural observations showing heterogeneity of granulosa cell population are presented in the study. At least two morphologically different subpopulations were identified: large, light coloured and small, darker cells. The expression of genes belonging to the mentioned ontological groups suggest the potential ability of GCs to differentiate and proliferate toward muscle lineage, showing possible application in muscle regeneration and the treatment of different diseases.Entities:
Keywords: human GCs; in vitro culture; muscle differentiation; proliferation
Year: 2020 PMID: 32604796 PMCID: PMC7355984 DOI: 10.3390/jcm9062006
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
The sequences of primes used for RT-qPCR analysis.
| Gene Name | Abbreviation | Primer Sequences F | Primer Sequences R | Ensembl Accession Number | Product Size (bp) |
|---|---|---|---|---|---|
| Oxytocin receptor | OXTR | TTCTTCGTGCAGATGTGGAG | GGACGAGTTGCTCTTTTTGC | ENSG00000111640 | 234 |
| Keratin 19 | KRT19 | TTTGAGACGGAACAGGCTCT | AATCCACCTCCACACTGACC | ENSG00000171345 | 211 |
| Epiregulin | EREG | CCAAGGACGGAAAATGCTTA | AAAATTAGCTGGGCATGGTG | ENSG00000124882 | 237 |
| Wingless-type MMTV integration site family, member 5A | WNT5A | TGGCTTTGGCCATATTTTTC | CCGATGTACTGCATGTGGTC | ENSG00000114251 | 199 |
| Transforming growth factor, beta receptor III | TGFBR3 | CCAAGATGAATGGCACACAC | CCATCTGGCCAACCACTACT | ENSG00000069702 | 151 |
| Prostaglandin-enderoperoxide synthase 2 | PTGS2 | TGAGCATCTACGGTTTGCTG | TGCTTGTCTGGAACAACTGC | ENSG00000073756 | 158 |
| Caveolin 1 | CAV1 | TCTCTACACCGTTCCCATCC | CAATCTTGACCACGTCATCG | ENSG00000105974 | 164 |
| Nexilin | NEXN | AAAAGAAGGCGTTTGCTGAA | CCTCTTCCTCTCCCATTTCC | ENSG00000162614 | 240 |
| Myosin light chain kinase | MYLK | TTGCTGAGGAAAAGCCTCAT | TTCCCGTCCTCATCGTAGTC | ENSG00000065534 | 193 |
| Cysteine and glycine-rich protein 3 | CSRP3 | CCTTGGCACAAGACCTGTTT | TTGTGTAAGGCCTCCAAACC | ENSG00000129170 | 150 |
| Actin, gamma 2, smooth muscle, enteric | ACTG2 | ACCCACAATGTCCCCATCTA | CTCCTTGATGTCTCGCACAA | ENSG00000163017 | 165 |
| Activating transcription factor 3 | ATF3 | CGCTGGAATCAGTCACTGTC | AGGCACTCCGTCTTCTCCTT | ENSG00000162772 | 160 |
| Tropomyosin 1 | TPM1 | GCTGGTTGAGGAAGAGTTGG | TCGCTCTCAATGATGACCAG | ENSG00000140416 | 246 |
| SRY (sex determining region Y) -box 9 | SOX9 | TTGAGCCTTAAAACGGTGCT | CTGGTGTTCTGAGAGGCACA | ENSG00000125398 | 244 |
| Phosphodiesterase 4b, cAMP-specific | PDE4B | GGAAAAATCCCAGGTTGGTT | AGTGGTGGTGAGGGACTTTG | ENSG00000184588 | 159 |
| Interleukin 4 receptor | IL4R | CAAGCTCTTGCCCTGTTTTC | TGCACAGAAGCTCCCTTTTT | ENSG00000077238 | 238 |
| 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | HTR7 | GAAGAGTGCTGCCAAACACA | GGTGGCTGCTTTCTGTTCTC | ENSG00000148680 | 181 |
| Collagen, type VI, alpha 3 | COL6A3 | ATCTCCTTCATCCCGGACTT | GGACCCATCGATGAGAAAGA | ENSG00000163359 | 192 |
| Interleukin 1, beta | IL1B | GGGCCTCAAGGAAAAGAATC | TTCTGCTTGAGAGGTGCTGA | ENSG00000125538 | 205 |
| Beta-actin | ACTB | AAAGACCTGTACGCCAACAC | CTCAGGAGGAGCAATGATCTTG | ENSG00000075624 | 132 |
| Hypoxanthine-guanine phosphoribosyltransferase | HPRT1 | TGGCGTCGTGATTAGTGATG | ACATCTCGAGCAAGACGTTC | ENSG00000165704 | 141 |
| Glyceraldehyde 3-phosphate dehydrogenase | GAPDH | TCAGCCGCATCTTCTTTTGC | ACGACCAAATCCGTTGACTC | ENSG00000111640 | 90 |
Figure 1Heatmaps presenting differentially expressed genes involved in “muscle cell development”, “muscle cell differentiation”, “muscle contraction”, “muscle organ development”, “muscle organ morphogenesis”, “muscle structure development”, “muscle system process” and “muscle tissue development” based on GO BP (Gene Ontology Biological Process) terms. Each row on the y-axis represents a single transcript. The red colour indicates the downregulated genes while the green the upregulated genes.
The 10 most significantly upregulated and 10 most significantly downregulated genes involved in muscle cells morphogenesis, structure, development and differentiation.
| Gene Symbol | Gene Name | Fold Change | Adj. p. val |
|---|---|---|---|
|
| Keratin 19 | 47.96 | 0.024 |
|
| Oxytocin receptor | 38.39 | 0.001 |
|
| Connective tissue growth factor | 36.07 | 0.003 |
|
| Nexilin (F actin binding protein) | 35.21 | 0.001 |
|
| Myosin light chain kinase | 27.45 | 0.003 |
|
| Cysteine and glycine-rich protein 3 (cardiac LIM protein) | 27.41 | 0.019 |
|
| Caveolin 1, caveolae protein, 22kDa | 22.41 | 0.002 |
|
| Actin, gamma 2, smooth muscle, enteric | 21.30 | 0.024 |
|
| Activating transcription factor 3 | 19.20 | 0.019 |
|
| Tropomyosin 1 (alpha) | 17.88 | <0.001 |
|
| SRY (sex determining region Y)-box 9 | −5.74 | 0.020 |
|
| Wingless-type MMTV integration site family, member 5A | −6.31 | 0.018 |
|
| Phosphodiesterase 4B, cAMP-specific | −7.09 | <0.001 |
|
| Interleukin 4 receptor | −8.22 | 0.003 |
|
| 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | −8.85 | 0.005 |
|
| Collagen, type VI, alpha 3 | −11.20 | 0.018 |
|
| Interleukin 1, beta | −14.49 | 0.027 |
|
| Transforming growth factor, beta receptor III | −20.43 | 0.021 |
|
| Prostaglandin-endoperioxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | −22.65 | 0.001 |
|
| Epiregulin | −98.98 | <0.001 |
Figure 2Analysis of enriched gene ontological groups involved in muscle cells morphogenesis, structure, development and differentiation. The network plot presenting the linkages of genes and GO BP terms.
Figure 3Interaction network of proteins encoded by the 50 most changed DEGs belonging to “muscle cell development”, “muscle cell differentiation”, “muscle contraction”, “muscle organ development”, “muscle organ morphogenesis”, “muscle structure development”, “muscle system process” and “muscle tissue development” GO BP terms. The network was generated by STRING software. Network nodes represent proteins. Empty nodes indicate proteins of unknown 3D structure.
Figure 4Microarray validation: RT-qPCR. The RT-qPCR results described validation of microarrays gene expression (log (FC)). Error bars represent the standard error mean (SEM; n = 3). All of the presented sample means were deemed to be statistically significant (p < 0.05). D: day of culture; FC: fold change.
Figure 5Photomicrographs of human ovarian granulosa cells during long-term culture. Day 1 (A–D); Day 7 (E–H); Day 15 (I–L); Day 30 (M–P); nucleus (N), pores in the nuclear membrane (*), smooth endoplasmic reticulum (SER), mitochondria (M), lipid vacuoles (L), rough endoplasmic reticulum (RER), topical widenings (C), Golgi apparatus (G), endosomes (E), multivesicular bodies (X), microvilli (V), nucleolus (N).
Figure 6Light microscope observations of changes in granulosa cell morphology during long-term in vitro culture. H—hour; D—day.